Point72 Hong Kong LTD Vista Gen Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.57 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.14 - $4.8 $1,748 - $59,956
12,491 Added 273.69%
17,055 $3,000
Q2 2022

Aug 15, 2022
SELL
$0.88 - $1.73 $7,215 - $14,184
-8,199 Reduced 64.24%
4,564 $4,000
Q1 2022

May 16, 2022
BUY
$1.14 - $2.09 $14,549 - $26,674
12,763 New
12,763 $16,000

Others Institutions Holding VTGN

# of Institutions
2
Shares Held
2.7M
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $623M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email